WuXi AppTec (OTCMKTS:WUXAY) Shares Down 7% – Here’s What Happened

WuXi AppTec Co., Ltd. (OTCMKTS:WUXAY)’s share price fell 7% on Friday . The company traded as low as $19.53 and last traded at $19.53. Approximately 144 shares were traded during trading, a decline of 93% from the average session volume of 2,174 shares. The stock had previously closed at $21.00.

Analyst Ratings Changes

Separately, Zacks Research upgraded WuXi AppTec to a “hold” rating in a report on Monday, April 13th. One research analyst has rated the stock with a Buy rating and one has given a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy”.

WuXi AppTec Stock Down 8.5%

The firm’s fifty day moving average is $17.42 and its 200-day moving average is $15.81.

WuXi AppTec (OTCMKTS:WUXAY) last announced its quarterly earnings data on Monday, April 27th. The company reported $0.23 earnings per share for the quarter, topping the consensus estimate of $0.18 by $0.05. The company had revenue of $1.82 billion for the quarter, compared to analyst estimates of $1.59 billion.

About WuXi AppTec

WuXi AppTec is a global contract research, development and manufacturing organization serving the pharmaceutical, biotechnology and medical device industries. Headquartered in Shanghai and founded in 2000, the company provides end-to-end solutions that span drug discovery, development and manufacturing. Its offerings enable customers to accelerate the research and development process for small molecules, biologics, cell and gene therapies, as well as medical devices.

Key services include chemistry and biology discovery support, preclinical safety assessment, analytical and formulation development, clinical manufacturing, large-scale biomanufacturing, and quality testing.